Monitoring
Creatinine should be measured every two weeks until the dosage is stable, then monthly. A full blood count, liver function tests and potassium should be measured periodically. Blood pressure should be closely monitored. Routine cyclosporin level monitoring is generally not required when it is used for indications other than transplantation; however, use of high doses should be guided by monitoring of blood levels. Patients not responding may also benefit from therapeutic drug monitoring, to rule out absorption problems and noncompliance.
Comments
Post a Comment